| NCT Number | NCT07213310 |
| Lead Sponsor | Daewoong Pharmaceutical Co. LTD. |
| Conditions | Healthy |
| Enrollment | 18 participants |
| Start Date | 2025-11-09 |
| Primary Completion | 2026-01-07 (estimated) |
| Study Completion | 2026-01-07 (estimated) |
| Updated on ClinicalTrials.gov | 2026-02-11 |